10 February 2018 in Theoretical Medicine and Bioethics
1 February 2019 in Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences
12 March 2020 in Lato Sensu: Revue de la Société de philosophie des sciences
Selon l’une des thèses les plus répétées de la médecine narrative, la théorie littéraire, ou plus largement, la narration, permettrait aux membres du personnel médical d’appréhender les récits des patients et par là, de prendre en considération leurs expériences dans leur singularité absolue. Dans ma contribution, je soulignerai quelques limites de cette thèse. J’appuierai mon analyse sur un exemple de récit dominant de maladie, les récits portant sur le cancer du sein aux États-Unis au XXe siècle, à partir des analyses féministes qui en ont été faites. Ainsi je montrerai d’une part qu’il est peu plausible que les récits des patients soient absolument singuliers et uniques, en un sens pertinent, et d’autre part que certains récits peuvent devenir dominants et marginaliser des récits qui voudraient s’en démarquer.
9 August 2021 in PLOS Biology
The purpose of biomedicine is to serve society, yet its hierarchical and closed structure excludes many citizens from the process of innovation. We propose a collection of reforms to better integrate citizens within the research community, reimagining biomedicine as more participatory, inclusive, and responsive to societal needs.
30 October 2025 in Studies in History and Philosophy of Science
This paper sets to explain how one of the most prescribed and sold pharmaceutical drugs in France - Spasfon (phloroglucinol), introduced on the French market in the 1960s, became and remained so successful in the absence of solid scientific evidence. Integrating the epistemology of ignorance and a feminist approach to the history of medicine, my goal is to understand how this case of ignorance was initially constructed and how it has maintained itself to this day. I argue that sexism is one key factor explaining how ignorance was constructed around this very popular - and incidentally pink - pharmaceutical drug.
27 September 2017 in Journal of Evaluation in Clinical Practice